BRANDI WYMER: Open Payments
NPI 1437583127 · GULF SHORES, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 15 payments from 8 companies in 2025. Trend: 2023 $42 · 2024 $107 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 3 | $65 |
| Exact Sciences Corporation | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| MILLICENT US INC | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: KISUNLA, Wegovy, Ozempic, The Cologuard Plus Collection Kit, XIFAXAN, INTRAROSA, Dexcom G6 Transmitter, NUZYRA.
Industry payments across AL — which companies pay providers there.
